LOM
Loeb Offshore Management Portfolio holdings
AUM
$543M
1-Year Return
49.52%
This Quarter Return
+16.33%
1 Year Return
+49.52%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$323M
AUM Growth
+$128M
(+66%)
Cap. Flow
+$114M
Cap. Flow
% of AUM
35.39%
Top 10 Holdings %
Top 10 Hldgs %
19.42%
Holding
265
New
129
Increased
54
Reduced
22
Closed
50
Top Buys
| 1 |
MetLife
MET
|
$7.58M |
| 2 |
Vodafone
VOD
|
$6.13M |
| 3 |
PVD
ADMIN FONDOS PENSIONS ADS(RP15
PVD
|
$5.46M |
| 4 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$5.27M |
| 5 |
SKS
SAKS INCORPORATED
SKS
|
$4.5M |
Top Sells
| 1 |
VIAB
Viacom Inc. Class B
VIAB
|
$7.5M |
| 2 |
CTB
Cooper Tire & Rubber Co.
CTB
|
$7.13M |
| 3 |
AGN
Allergan plc
AGN
|
$6.29M |
| 4 |
BMC
BMC SOFTWARE, INC
BMC
|
$5.64M |
| 5 |
SFD
SMITHFIELD FOODS,INC
SFD
|
$5.59M |
Sector Composition
| 1 | Financials | 11.63% |
| 2 | Healthcare | 10.7% |
| 3 | Technology | 10.6% |
| 4 | Communication Services | 9.27% |
| 5 | Consumer Discretionary | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
151
DELISTED
Celgene Corp
CELG
| $369K | 0.11% |
+4,786
| New | +$369K |
|
152
Sarepta Therapeutics
SRPT
$1.96B
| $359K | 0.11% |
+7,598
| New | +$359K |
|
|
ANLY
153
DELISTED
ANALYSTS INTL CORP COM STK (MN)
ANLY
| $354K | 0.11% |
+55,000
| New | +$354K |
|
154
Terex
TEX
$3.47B
| $346K | 0.11% |
+10,283
| New | +$346K |
|
155
MBIA
MBI
$377M
| $335K | 0.1% |
+32,767
| New | +$335K |
|
156
Pfizer
PFE
$141B
| $328K | 0.1% |
12,034
-15,370
| -56% | -$419K |
|
157
Cardinal Health
CAH
$35.7B
| $327K | 0.1% |
6,269
+1,369
| +28% | +$71.4K |
|
158
Amgen
AMGN
$153B
| $323K | 0.1% |
2,883
-117
| -4% | -$13.1K |
|
|
PRTK
159
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $321K | 0.1% |
+8,417
| New | +$321K |
|
|
WNR
160
DELISTED
Western Refining Inc
WNR
| $300K | 0.09% |
+10,000
| New | +$300K |
|
161
Zimmer Biomet
ZBH
$20.9B
| $292K | 0.09% |
+3,660
| New | +$292K |
|
|
AGN
162
DELISTED
ALLERGAN INC
AGN
| $289K | 0.09% |
+3,192
| New | +$289K |
|
163
Vertex Pharmaceuticals
VRTX
$102B
| $279K | 0.09% |
+3,683
| New | +$279K |
|
|
PCYC
164
DELISTED
PHARMACYCLICS INC
PCYC
| $273K | 0.08% |
1,974
-1,276
| -39% | -$176K |
|
|
MDVN
165
DELISTED
MEDIVATION, INC.
MDVN
| $272K | 0.08% |
9,078
-138,572
| -94% | -$4.15M |
|
166
Biogen
BIIB
$20.6B
| $271K | 0.08% |
1,125
+125
| +13% | +$30.1K |
|
167
Brookdale Senior Living
BKD
$1.83B
| $271K | 0.08% |
+10,296
| New | +$271K |
|
|
ISS
168
DELISTED
ISOFTSTONE HLDGS LTD ADS EACH REPSTG 10 ORD SHS (CYM)
ISS
| $270K | 0.08% |
54,910
+24,910
| +83% | +$122K |
|
169
Viatris
VTRS
$12.2B
| $269K | 0.08% |
+7,050
| New | +$269K |
|
170
Regeneron Pharmaceuticals
REGN
$60.8B
| $264K | 0.08% |
+845
| New | +$264K |
|
|
TRIB
171
Trinity Biotech
TRIB
$4.32M
| $264K | 0.08% |
+2,429
| New | +$264K |
|
172
Grifois
GRFS
$6.89B
| $257K | 0.08% |
+17,000
| New | +$257K |
|
173
Eli Lilly
LLY
$652B
| $255K | 0.08% |
+5,075
| New | +$255K |
|
|
SNTS
174
DELISTED
SANTARUS INC
SNTS
| $253K | 0.08% |
+11,198
| New | +$253K |
|
175
Jazz Pharmaceuticals
JAZZ
$7.86B
| $246K | 0.08% |
+2,673
| New | +$246K |
|